Home › Cancer (all types)
Cancer (all types) clinical trials recruiting in the U.S.
618 studies for Cancer (all types) are recruiting participants at sites across the United States.
If you or someone you love has been diagnosed with cancer, learn about diagnosis, treatment, risk factors, coping and much more.
Cities with the most studies
- Houston, TX123 studies
- New York City, NY111 studies
- Boston, MA86 studies
- Los Angeles, CA73 studies
- Nashville, TN64 studies
- Philadelphia, PA60 studies
- Washington, DC60 studies
- Durham, NC59 studies
- Chicago, IL52 studies
- Seattle, WA50 studies
- Atlanta, GA50 studies
- Arlington, VA49 studies
- St. Louis, MO46 studies
- Pittsburgh, PA41 studies
- Mountain View, CA41 studies
- San Antonio, TX41 studies
- Columbus, OH39 studies
- Tampa, FL39 studies
- Baltimore, MD38 studies
- Dallas, TX38 studies
- Cleveland, OH37 studies
- Miami, FL36 studies
- Portland, OR36 studies
- Aurora, CO35 studies
- San Francisco, CA35 studies
- New Haven, CT34 studies
- San Diego, CA33 studies
- Edison, NJ33 studies
- Birmingham, AL31 studies
- Memphis, TN31 studies
- Baldwin Park, CA31 studies
- Rochester, MN31 studies
- Jacksonville, FL30 studies
- Detroit, MI29 studies
- Grand Rapids, MI29 studies
- Salt Lake City, UT28 studies
- Cincinnati, OH28 studies
- Charlotte, NC27 studies
- Queens, NY26 studies
- Ann Arbor, MI26 studies
By state
- Alabama37 studies
- Alaska4 studies
- Arizona52 studies
- Arkansas23 studies
- California174 studies
- Colorado56 studies
- Connecticut45 studies
- Delaware10 studies
- District of Columbia26 studies
- Florida130 studies
- Georgia64 studies
- Hawaii13 studies
- Idaho5 studies
- Illinois68 studies
- Indiana32 studies
- Iowa18 studies
- Kansas20 studies
- Kentucky27 studies
- Louisiana20 studies
- Maine6 studies
- Maryland71 studies
- Massachusetts97 studies
- Michigan75 studies
- Minnesota51 studies
- Mississippi8 studies
- Missouri57 studies
- Montana4 studies
- Nebraska23 studies
- Nevada14 studies
- New Hampshire12 studies
- New Jersey62 studies
- New Mexico17 studies
- New York142 studies
- North Carolina91 studies
- North Dakota12 studies
- Ohio87 studies
- Oklahoma16 studies
- Oregon43 studies
- Pennsylvania103 studies
- Rhode Island13 studies
- South Carolina31 studies
- South Dakota14 studies
- Tennessee90 studies
- Texas186 studies
- Utah40 studies
- Vermont7 studies
- Virginia73 studies
- Washington59 studies
- West Virginia8 studies
- Wisconsin40 studies
Recently updated studies
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06881992Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
RecruitingPhase 1/2
Ages 18 to 99 · All sexes · Updated Sep 28, 2026 · NCT07416188A Study of Music Therapy for Anxiety in People With Cancer
Recruiting
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07845422EXERT-BC Protein: Protein Supplementation to Improve Body Composition After Treatment for Breast Cancer
Recruiting
Ages 20 to 89 · Women · Updated Sep 28, 2026 · NCT07704476Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RecruitingObservational study
Ages 3 and older · All sexes · Updated Sep 28, 2026 · NCT01441089Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
RecruitingObservational study
Ages 18 to 120 · All sexes · Updated Sep 28, 2026 · NCT00006518A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07409246A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06884618Collection of Blood From Patients With Cancer
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT00034216Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
RecruitingPhase 3
Ages 18 and older · Women · Updated Sep 28, 2026 · NCT05256225Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
RecruitingObservational studyHealthy volunteers welcome
Ages 2 and older · All sexes · Updated Sep 28, 2026 · NCT00033137Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
RecruitingPhase 2
Ages 18 to 120 · All sexes · Updated Sep 28, 2026 · NCT04449549Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
RecruitingObservational studyHealthy volunteers welcome
4 Weeks · All sexes · Updated Sep 28, 2026 · NCT01109394Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07493304A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07612176SAFE.AI: Developing and Testing an AI-based Hybrid Chatbot for Financial Empowerment in Rural Cancer Care
Recruiting
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07410689A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06989437Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT04981119First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07438782A Study of JNJ-87890387 for Advanced Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06178614A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07155187Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life
Recruiting
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06667427A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Sep 25, 2026 · NCT05920356A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06150157Clinical Study of MK-4884 in Participants With Advanced or Metastatic Solid Tumors (MK-4884-001)
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07600749From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.